# Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma

> **NCT00867906** · PHASE2 · COMPLETED · sponsor: **Circassia Limited** · enrollment: 48 (estimated)

## Conditions studied

- Cat Allergy

## Interventions

- **BIOLOGICAL:** Cat-PAD
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00867906
- **Lead sponsor:** Circassia Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2010-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867906, "Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00867906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*